Clinical Trial Update: Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study). [Phase 1, Phase 2]

View source ↗

Summary

This entry describes a Phase Ib/IIa dose-escalation and expansion trial of the radiopharmaceutical [212Pb]Pb-ADVC001 for metastatic prostate cancer (including m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Hormone-sensitive Prostate Cancer
• Prostate Cancer

Drugs mentioned

• [212Pb]Pb-ADVC001 (ADVC001)

Snippet

Sponsor: AdvanCell Pty Limited | Conditions: Prostate Cancer, Metastatic Castration-resistant Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING